25 of the Best Hematologists Near Me

Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma. Dr. Marks is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Marks is currently accepting new patients.

Philosophy of care | As a physician dedicated to the comprehensive care of cancer patients, my philosophy centers on empathy, communication and personalized treatment. I build a trusting and compassionate relationship with my patients, ensuring they are fully informed about their condition and treatment options. I am committed to understanding their unique goals and wishes and tailoring their treatment plans accordingly. I integrate leading-edge advancements by offering participation in clinical trials, contributing to the progress of oncology care. My goal is not only to provide exceptional medical expertise, but also to support and empower patients, fostering collaboration that prioritizes physical and emotional well-being. | Why I entered medicine | I chose a medical career with a specific focus on cancer care because it offered me the opportunity to seamlessly merge the dynamic advancements in cancer biology with the profound personal connections essential for understanding and supporting my patients. The ever-evolving science of cancer has fascinated me, driving my commitment to staying at the forefront of breakthroughs and innovations. However, it is the deeply personal nature of medicine that truly inspires me – the privilege of learning about my patients, understanding their unique stories and collaborating with them as they heal. This dual passion for scientific progress and compassionate patient care motivates me. | Community involvement | I contribute to public education with the presentation, detection and treatment of lung cancers. In doing so I empower individuals with knowledge, foster early detection and encourage proactive engagement in their lung health. | Personal interests | I have a deep love for exploring diverse cultures through culinary adventures, mastering the art of cooking international cuisine and indulging in the creativity of baking. I am also passionate about personal fitness, recognizing the importance of a healthy and balanced lifestyle. My love for international travel serves as inspiration, allowing me to broaden my perspectives and immerse myself in different societies. Such pursuits allow me to connect with patients on a more personal level, fostering a holistic approach to health care. Dr. Patson is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Patson is board certified in American Board Of Internal Medicine - Medical Oncology , American Board Of Internal Medicine - Internal Medicine, and American Board Of Internal Medicine - Hematology . Dr. Patson is currently accepting new patients.

Narotham Thudi is a Hematologist and an Oncologist practicing medicine in Irving, Texas. Dr. Thudi is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Non-Hodgkin Lymphoma, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. Dr. Thudi is board certified in Medical Oncology- American Board Of Internal Medicine, Hematology- American Board Of Internal Med/Hematology, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Medicine, and Hematology- American Board Of Internal Medicine. Dr. Thudi is currently accepting new patients.

Patricia Kropf is a Hematologist practicing medicine in Charlotte, North Carolina. Dr. Kropf is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kropf is currently accepting new patients.

Jason Bierenbaum, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Bierenbaum specializes in lung cancer, gastrointestinal cancers, and myelodysplasia. Dr. Bierenbaum is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Childhood Iron Deficiency Anemia. Dr. Bierenbaum is board certified in American Board Of Internal Medicine. Dr. Bierenbaum is currently accepting new patients.

Lydia Clements is a Hematologist and an Oncologist practicing medicine in Newark, Delaware. Dr. Clements is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Anemia, HER-2 Positive Breast Cancer, and Bone Marrow Aspiration. Dr. Clements is currently accepting new patients.

Lijun Dai, MD, PhD, is a medical oncologist/hematologist at UPMC Hillman Cancer Center. She has a clinical interest in the management of hematological disorders and the treatment of all cancers including breast cancer, gastrointestinal cancer, and lung cancer. Dr. Dai is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Anemia, Inflammatory Breast Cancer, Paget Disease of the Breast, and Thrombocytopenia. Dr. Dai is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Dai is currently accepting new patients.

Maria Varas is a Hematologist Oncology provider practicing medicine in Weston, Florida. Dr. Varas is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Idiopathic Neutropenia, and Thrombocytopenia. Dr. Varas is board certified in American Board Of Internal Medicine, 2018. Dr. Varas is currently accepting new patients.

Kasra Karamlou is a Hematologist and an Oncologist practicing medicine in Lorain, Ohio. He has been practicing medicine for over 34 years. Dr. Karamlou is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Monoclonal Gammopathy of Undetermined Significance (MGUS), Unicentric Castleman Disease (UCD), and Multicentric Castleman Disease (MCD). Dr. Karamlou is board certified in American Board Of Internal Medicine, 2003. Dr. Karamlou is currently accepting new patients.

Umang Gautam is a Hematologist and an Oncologist practicing medicine in Green Bay, Wisconsin. Dr. Gautam is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Adult Soft Tissue Sarcoma, Clear Cell Sarcoma, and Bone Marrow Aspiration. Dr. Gautam is board certified in American Board Of Internal Medicine, Hematology. Dr. Gautam is currently accepting new patients.

Juan Alderuccio is a Hematologist practicing medicine in Miami, Florida. Dr. Alderuccio is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Marginal Zone Lymphoma (MZL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL). Dr. Alderuccio is currently accepting new patients.

Joseph Pidala is a Hematologist and an Oncologist practicing medicine in Tampa, Florida. Dr. Pidala is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Pidala is currently accepting new patients.

Kieron Dunleavy is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Dunleavy is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Burkitt Lymphoma, and Bone Marrow Aspiration. Dr. Dunleavy is currently accepting new patients.

Timothy Hobday is a Hematologist and an Oncologist practicing medicine in Rochester, Minnesota. Dr. Hobday is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Embryonal Tumor with Multilayered Rosettes, Pancreatic Cancer, and Liver Embolization. Dr. Hobday is currently accepting new patients.

Dr. Jad Chahoud is the chief scientific and innovation officer with Orlando Health Cancer Institute, where he drives the organization's vision for research excellence and technology-enabled innovation. In this role, he leads strategic initiatives to advance clinical trials, strengthen research infrastructure and integrate cutting-edge technologies that position Orlando Health as a national leader in patient-centered care and scientific advancement. He also is a board-certified medical oncologist and expert in treating advanced genitourinary cancers. Dr. Chahoud is passionate about transforming research operations through AI-enabled clinical trial systems and expanding patient access to groundbreaking therapies across Florida. Dr. Chahoud's Training Dr. Chahoud received his medical training at Lebanese University in Beirut, Lebanon. He completed an internal medicine residency at the University of Texas Health Science Center in Houston and a hematology and medical oncology fellowship at the University of Texas MD Anderson Cancer Center in Houston. He also earned a Master of Public Health and Master of Health Administration (MPH-MHA) from the University of Texas. About Dr. Chahoud Dr. Chahoud is board certified in hematology, medical oncology and internal medicine by the American Board of Internal Medicine. His professional memberships include the American Society of Clinical Oncology, American Association of Cancer Research, European Society of Medical Oncology and Society for Immunotherapy of Cancer. A nationally recognized clinician, scientist and expert in advanced genitourinary cancers, Dr. Chahoud has led numerous first-in-human and investigator-initiated studies and is internationally known for his research on renal cell carcinoma and rare malignancies. His work has been published in numerous top-tier medical journals, including The Lancet, Journal of Clinical Oncology and Nature. Outside of work, he enjoys spending time with family. Dr. Chahoud is fluent in English, Spanish, French and Arabic. Dr. Chahoud is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Penile Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Penectomy, and Nephrectomy. Dr. Chahoud is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine. Dr. Chahoud is currently accepting new patients.

Steven Devine is a Hematologist practicing medicine in Columbus, Ohio. Dr. Devine is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Graft.

Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Orchiectomy. Dr. Ho is currently accepting new patients.

Kelly Godby is a Hematologist practicing medicine in Birmingham, Alabama. Dr. Godby is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Schnitzler Syndrome, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Godby is currently accepting new patients.

Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Petro is board certified in American Board Of Internal Medicine. Dr. Petro is currently accepting new patients.

Byram Ozer is a Hematologist Oncology specialist and a Hematologist practicing medicine in Atlanta, Georgia. Dr. Ozer is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor. Dr. Ozer is board certified in United Council For Neurological Subspecialties, 2019. Dr. Ozer is currently accepting new patients.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemolytic Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia. Dr. Naik is board certified in American Board Of Internal Medicine. Dr. Naik is currently accepting new patients.

Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dorritie is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Dorritie is currently accepting new patients.

Emerson Lim is a Hematologist Oncology specialist and an Oncologist practicing medicine in Fremont, Michigan. Dr. Lim is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Lim is board certified in American Board Of Internal Medicine. Dr. Lim is currently accepting new patients.

Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease. Dr. Kamble is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft. Dr. Kamble is board certified in American Board Of Internal MedicineAmerican Board Of Internal Medicine, Medical Oncology. Dr. Kamble is currently accepting new patients.

Adam Cohen is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Cohen is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Primary Amyloidosis, and Bone Marrow Aspiration. Dr. Cohen is board certified in Hematology, 2007 and Medical Oncology, 2005. Dr. Cohen is currently accepting new patients.